Eli Lilly launched a charitable initiative supporting community organizations to distribute 500,000 nutritious meals across 15 U.S. communities as part of its 150th anniversary. The company also funds cold storage infrastructure for 150 food pantries, enabling the delivery of an estimated five million protein-rich meals annually. This effort, in partnership with groups like HATCH, United Way, and the Pacers Foundation, aims to improve long-term access to nutritious food, reflecting Lilly's view that food is essential to health. The initiative includes ongoing volunteer activities and will culminate in Lilly's Global Day of Service in September.
Eli Lilly's late-phase trials SURMOUNT-MAINTAIN and ATTAIN-MAINTAIN show that adults with obesity maintained most of their weight loss after switching from high doses of injectable therapies Wegovy and Zepbound to either oral Foundayo or lower-dose Z...
Nvidia's market capitalization recently exceeded $5.3 trillion, surpassing the combined value of all 59 healthcare companies in the S&P 500, which total about $5.2 trillion. This shift highlights the massive investor confidence in AI infrastructure, ...
Eli Lilly reported a strong Q1 2026 with revenue up 55.5% to $19.8 billion and earnings per share beating estimates. Its drug Mounjaro became the world's top-selling medication, driving optimism and a raised full-year revenue forecast of $82-$85 bill...
Eli Lilly's stock surged after a strong Q1 report with revenue up 55.55% year-over-year and raised full-year guidance, yet it remains down 10% year-to-date. The company’s GLP-1 drugs Mounjaro and Zepbound showed significant growth, but pricing pressu...
Eli Lilly reported a strong Q1 2026 with 55.55% revenue growth to $19.8 billion, driven by blockbuster drugs Mounjaro and Zepbound, and raised its full-year revenue guidance. The company is investing aggressively in AI drug discovery and acquisitions...
